In:
International Journal of Cancer, Wiley, Vol. 138, No. 7 ( 2016-04), p. 1765-1776
Kurzfassung:
What's New? The extreme molecular diversity of tumors is a major obstacle to the precise stratification and treatment of cancers, and to overcome it, clinicians have increasingly turned to in‐depth genotypic and phenotypic tumor characterization. To assist in that process, the authors of the present study developed DrugTargetInspector (DTI), a web‐based tool suite that analyzes patient‐specific –omics datasets for the identification of tumor characteristics and relevant treatment options. DTI draws on information from across multiple databases to detect mutations, deregulated drug targets, and recommended drug options. The platform is a valuable addition to existing decision‐support mechanisms for cancer therapy.
Materialart:
Online-Ressource
ISSN:
0020-7136
,
1097-0215
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2016
ZDB Id:
218257-9
ZDB Id:
1474822-8